Research map: Biomarkers, mechanisms, and precision care in thrombosis

Back to the article

Papers in this map

  1. Elevated plasma complement factor H related 5 protein is associated with venous thromboembolism · María Jesús Iglesias · 2023 · 38 citations · Cited by this paper
  2. Thrombus composition in ischaemic stroke: histological and radiological evaluation, and implications for acute clinical management · Esmee Dohle · 2025 · 16 citations · Cited by this paper
  3. The COVID-19 thrombus: distinguishing pathological, mechanistic, and phenotypic features and management · Richard C. Becker · 2024 · 11 citations · Cited by this paper
  4. Persistent hypofibrinolysis in severe COVID-19 associated with elevated fibrinolysis inhibitors activity · Erica Okazaki · 2024 · 9 citations · Cited by this paper
  5. Predictors of futile recanalization after intravenous thrombolysis in stroke patients transferred for endovascular treatment · Lucio D’Anna · 2025 · 7 citations · Cited by this paper
  6. Real-world outcomes of oral anticoagulation in patients with atrial fibrillation at high risk of both bleeding and stroke: observational evidence from three international registries from middle East, Europe and Asia-Pacific · Amir Askarinejad · 2025 · 4 citations · Cited by this paper
  7. ET1 acts as a potential plasma biomarker and therapeutic target in deep venous thrombosis rat model · Zhanqi Wang · 2024 · 3 citations · Cited by this paper
  8. Potential association of TGFβ1 plasma levels and fibrinolysis parameters with the risk of recurrence and vascular obstruction after a first unprovoked pulmonary embolism episode · Marc Danguy des Déserts · 2025 · 2 citations · Cited by this paper
  9. The association of angiostatin and plasminogen plasma levels with Charlson comorbidity burden and mortality in COVID-19 · Aleksandra Franczak · 2026 · 1 citation · Cited by this paper
  10. Antiplatelet effects of oral anticoagulants in patients with atrial fibrillation: ex-vivo studies · Giulia Renda · 2026 · 1 citation · Cited by this paper
  11. Association of thrombogenicity indices with perioperative cardiovascular events after non-cardiac surgery: a prespecified analysis of the PANDA study · Hendrianus Hendrianus · 2026 · 1 citation · Cited by this paper
  12. Association of IgA antiphospholipid antibodies with hypercoagulability and inflammation in antiphospholipid syndrome · Isabella Constantini Soares de Andrade · 2026 · 1 citation · Cited by this paper
  13. Complement Factor H as a Novel Predictive Biomarker for Deep Vein Thrombosis Recurrence: A Prospective Cohort Study · Yi Hua Qian · 2026 · 1 citation · Cited by this paper
  14. Platelet FcɣRIIa: a novel biomarker of risk for thromboembolism and death in cancer · Chris E. Holmes · 2026 · 1 citation · Cited by this paper
  15. Thrombotic molecular markers after intravenous thrombolysis are associated with early neurological deterioration in acute ischemic stroke · Wei Sun · 2026 · 1 citation · Cited by this paper
  16. Circulating cfdna: A novel biomarker for preventing early recurrence in ischemic stroke · Xinglan Li · 2025 · 1 citation · Cited by this paper
  17. miR-4443 alleviates myocardial injury in acute myocardial infarction by targeting and regulating TIMP2 · Huihui Zhu · 2026 · 1 citation · Cited by this paper
  18. Clinical outcomes of anemia in patients with spontaneous coronary artery dissection: a retrospective cohort analysis · Emmanuel Olusoji Olumuyide · 2026 · 1 citation · Cited by this paper
  19. Edoxaban for atrial fibrillation in patients with atherosclerotic disease in daily clinical practice · Tim A.C. de Vries · 2026 · 1 citation · Cited by this paper
  20. Combined circuit-directed (pre-oxygenator) nafamostat and low-dose systemic unfractionated heparin anticoagulation in ecmo patients with high bleeding risk: A case series and safety evaluation · Yunjiu Hu · 2026 · 1 citation · Cited by this paper

Source: OpenAlex (CC0)